Tremor
TrialsCompanies

Not investment advice.

Tremor shows what changed in public records. It never tells anyone to buy or sell. Many trial edits are harmless paperwork. Data from ClinicalTrials.gov, the SEC, and the Federal Register.

PrivacyTerms

RADX

Radiopharm Theranostics Ltd

Tremor tracks 3 of its cancer trials.

Company-wide warning signs

These add points to every one of this company's trials.

None right now.

Trials

  • RADXRadiopharm Theranostics, Ltd
    0Calm

    177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

    Signing up patientsPhase 1/261 patientsMain results: Dec 2027
  • RADXRadiopharm Theranostics, Ltd
    0Calm

    Phase 2b Imaging Study of RAD101 in Participants With Suspected Recurrent Brain Metastases

    Running, no new patientsPhase 230 patientsMain results: Apr 23, 2026
  • RADXRadiopharm Theranostics, Ltd
    0Calm

    A Study of Terbium 161 (161Tb)-RAD402 in Participants With CRPC

    Signing up patientsPhase 1/273 patientsMain results: Nov 30, 2028

Key executives leaving

From the last 12 months of the company's SEC reports.

None found.

Insider trades (last 6 months)

“Insiders” are executives, board members, and big shareholders. Many of their sales are pre-planned: scheduled months ahead under a legal plan (called 10b5-1), so they usually say little. Tremor only counts sales that weren't pre-planned.

0 sales (0 not pre-planned) · 0 purchases

No insider sales or purchases in the last 6 months.

Recent SEC filings

Public companies must report important news and their finances to the SEC, the US agency that oversees the stock market.

  • New shares being soldNew shares being sold (424B5)Jul 27, 2026
  • New shares being soldNew shares being sold (424B5)Jul 23, 2026

Money left

Coming soon: how many months of cash the company has, from its quarterly reports.